ArticleCureus2025
Disparities in Industry Payments to Orthopedic Surgeons: A Retrospective Observational Analysis of Institutional Prestige and Financial Distribution.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Disparities in Industry Payments Between Orthopaedic Surgery and General Surgery Residents.JB & JS open accessReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Financial relationships between orthopedic surgeons and industry partners shape innovation and surgical advancements, yet these payments are highly concentrated among a small subset of surgeons. This retrospective observational analysis examines industry payment disparities using the Centers for Medicare & Medicaid Services (CMS) Open Payments Database for 2021, comparing payments between orthopedic surgeons affiliated with U.S. News & World Report (USNWR) top 10 orthopedic centers and those at large academic medical centers in the 25 most populous U.S. states. A total of 1,612 surgeons were included. Industry payments exhibited a right-skewed distribution, with a Gini coefficient of 0.91 for USNWR institutions and 0.93 for state-based academic centers, indicating significant financial stratification. Royalty and licensing fees accounted for 93.25% of payments exceeding $500,000, disproportionately benefiting surgeons at USNWR-ranked institutions. Surgeons at these institutions had 3.01 times higher odds of receiving over $500,000 in payments compared to those at state medical centers (OR = 3.01, 95% CI: 1.50-6.04, p < 0.001). Geographic disparities were also significant, with payments concentrated in states housing top-tier orthopedic programs. These findings highlight the role of institutional prestige in industry compensation and raise ethical considerations regarding equity in financial relationships and access to industry collaborations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.